Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

854
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
854
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

494
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
494
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.5K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.5K
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

611
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
611

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrocaloric effects across room temperature in multilayer capacitors.

Nature·2026
Same author

Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary: A Systematic Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

Canadian journal of surgery. Journal canadien de chirurgie·2023

Related Experiment Video

Updated: Apr 5, 2026

Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation
09:23

Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation

Published on: August 18, 2016

11.0K

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

E Tsvetkova1, S Sud1, N Aucoin2

  • 1The Ottawa Hospital Cancer Centre, Ottawa, ON;

Current Oncology (Toronto, Ont.)
|August 25, 2015
PubMed
Summary

The Eastern Canadian Colorectal Cancer Consensus Conference convened experts to discuss and establish consensus on managing gastrointestinal malignancies, including pancreatic and colorectal cancers.

Keywords:
Neuroendocrine tumoursRAS testingchemotherapycolorectal cancerpancreatic cancerradiation therapyscreening

More Related Videos

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

17.6K
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.7K

Related Experiment Videos

Last Updated: Apr 5, 2026

Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation
09:23

Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation

Published on: August 18, 2016

11.0K
Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

17.6K
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.7K

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • The Eastern Canadian Colorectal Cancer Consensus Conference is an annual meeting.
  • It brings together experts in radiation, medical, and surgical oncology, as well as pathologists.
  • These specialists focus on the management of gastrointestinal malignancies.

Purpose of the Study:

  • To present and discuss current management strategies for complex gastrointestinal cancers.
  • To generate consensus statements on critical and evolving topics in the field.
  • To foster collaboration and knowledge exchange among leading oncologists and pathologists.

Main Methods:

  • The conference involved presentations and expert discussions.
  • Key topics included neuroendocrine tumors, advanced pancreatic cancer, and metastatic colorectal cancer.
  • Consensus statements were developed based on these discussions.

Main Results:

  • Consensus was reached on several "hot topics" in gastrointestinal oncology.
  • Specific areas of focus included neuroendocrine tumors, advanced and metastatic pancreatic cancer, and metastatic colorectal cancer.
  • The outcomes provide guidance for clinical practice.

Conclusions:

  • The conference successfully facilitated expert consensus on the management of challenging gastrointestinal malignancies.
  • The generated statements offer valuable insights for oncologists and pathologists.
  • This collaborative effort aims to improve patient care for gastrointestinal cancers.